Reaction
Type V Hyperlipidaemia reporting signals
As of the last recalculation, Type V Hyperlipidaemia appears in 470 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is EPLERENONE (PRR 72.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eplerenone | 20 | 72.2 | 72.3 |
| Methimazole | 8 | 45.9 | 45.9 |
| Liothyronine Sodium | 8 | 41.4 | 41.4 |
| Prochlorperazine Maleate | 8 | 39.1 | 39.1 |
| Dapagliflozin | 21 | 30.9 | 30.9 |
| Tafamidis | 4 | 15.2 | 15.2 |